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Summary
Human NDR1 and 2 (NDR1/2) are serine-threonine protein ki-
nases in a subgroup of the AGC kinase family [1]. The mech-
anisms of physiological NDR1/2 activation and their function
remain largely unknown. Here we report that Fas and TNF-a
receptor stimulation activates human NDR1/2 by promoting
phosphorylation at the hydrophobic motif (Thr444/442).
Moreover, NDR1/2 are essential for Fas receptor-induced ap-
optosis as shown by the fact that NDR knockdown signifi-
cantly reduced cell death whereas overexpression of the
NDR1 kinase further potentiated apoptosis. Activation of
NDR1/2 by death receptor stimulation is mediated by the tu-
mor suppressor RASSF1A. Furthermore, RASSF1A-induced
apoptosis largely depends on the presence of NDR1/2. Fas
receptor stimulation promoted direct phosphorylation and
activation of NDR1/2 by the mammalian STE20-like kinase 1
(MST1), a downstream effector of RASSF1A. Concurrently,
the NDR1/2 coactivator MOB1 induced MST1-NDR-MOB1
complex formation, which is crucial for MST1-induced
NDR1/2 phosphorylation upon induction of apoptosis. Our
findings identify NDR1/2 as novel proapoptotic kinases
and key members of the RASSF1A/MST1 signaling cascade.
Results and Discussion
Apoptotic pathways, including those induced by death recep-
tors, are often suppressed in cancer cells through the inactiva-
tion of corresponding tumor suppressors, which normally
resist cell overgrowth [2–4]. RASSF1A (Ras association do-
main family 1 isoform A) is a well-known tumor suppressor
protein encoded by a gene on human chromosome 3 at
p21.3 and is often silenced by promoter hypermethylation in
a wide variety of human cancers [2, 5]. Reintroduction of
RASSF1A was reported to induce cell-cycle inhibition via inac-
tivation of the APC/Cdc20 complex [6] or apoptosis via MST1
or MST2 [7, 8]. Although MST2 is known to signal through
LATS1/2 [8–10], the apoptotic signaling cascade downstream
of MST1 in mammalian cells remains obscure.
NDR1/2 are serine-threonine protein kinases belonging to an
AGC kinase subfamily implicated in many essential processes
such as cell division and proliferation [1]. So far the only known
function implicates NDR1 in the regulation of centrosome du-
plication [11]. Two phosphorylation sites of human NDR1/2,
Ser281/282 and Thr444/442, are essential for full kinase
*Correspondence: brian.hemmings@fmi.ch
2These authors contributed equally to this workactivation in vitro and in vivo [12, 13]. The binding of coactiva-
tor MOB1A to the N terminus of NDR1/2 stimulates kinase ac-
tivity, which results in autophosphorylation on Ser281/282 at
the activation segment [14].
We reported earlier that MST3 kinase can phosphorylate
NDR1/2 at Thr444/442 in the hydrophobic motif [15]. Although
no physiological stimulus has been reported for the MST3
kinase, close members within the MST kinase family, such as
MST1 and MST2, are actively involved in apoptosis and stress
response [16–20]. To determine whether NDR1/2 are regulated
by apoptotic stimuli, we treated HeLa cells with the Fas anti-
body or TNF-a. We observed a robust induction of NDR1/2
phosphorylation at Thr444/442, but total NDR1/2 did not
change. This NDR1/2 phosphorylation was paralleled by acti-
vation of MST1/2 and by PARP cleavage, confirming the onset
of apoptosis (Figure 1A, top). Similar results were obtained
with Jurkat cells (Figure S1A available online). The kinase ac-
tivity of endogenous NDR1/2 increased significantly (more
than 8-fold) in cells undergoing Fas and TNF-a receptor stim-
ulation, indicating NDR1/2 activation during apoptosis
(Figure 1A, bottom). These data are the first indication of
a physiological stimulation of NDR kinases.
It has been reported that Fas receptor stimulation triggers
RASSF1A-dependent activation of the downstream signaling
cascade [7, 8]. Indeed, expression of RASSF1A was sufficient
to promote NDR1/2 activation, comparable to induction by the
Fas receptor (Figure 1B, top). Moreover, localization of activated
NDR1/2 and RASSF1A partially overlapped in the cytoplasm
(Figure 1B, bottom). Decreased levels of RASSF1A protein in
cells treated with the Fas antibody resulted in impaired NDR
Thr444/442 phosphorylation, indicating that the Fas-depen-
dent apoptotic signaling cascade activating NDR kinases is
mediated by RASSF1A (Figure 1C).
RASSF1A protein was shown to exert its proapoptotic
effects via MST1 and MST2 kinases [7, 8, 21]. In Fas receptor-
induced apoptosis, MST2 transmits an apoptotic signal to
LATS1; however, no downstream target of MST1 has yet
been proposed. To investigate whether MST1 is involved in
the regulation of NDR Thr444/442 phosphorylation, the level
of the endogenous MST1 kinase was decreased by shRNA.
Stimulation of NDR Thr444/442 phosphorylation upon Fas an-
tibody treatment failed in cells with low MST1 content
(Figure 1D), demonstrating the importance of MST1 for the
NDR1/2 activation during apoptosis. Transient knockdown of
MST2 resulted in only moderate downregulation of NDR1/2
phosphorylation under the same experimental conditions
(Figure S1B). Consistent with these data, we also found re-
duced NDR Thr444/442 phosphorylation triggered by the ex-
pression of RASSF1A in MST1 knockdown cells (Figure 1E).
In addition, NDR1/2 kinase activity was stimulated by the non-
specific inducer of apoptosis, actinomycin D (Figure S1C).
Knockdown of MST1 efficiently prevented NDR1/2 phosphor-
ylation, induced by actinomycin D, whereas knockdown of
MST3 did not change the level of phosphorylated NDR
(Figure S1D).
Because MST1 kinase was crucial for the activation of
NDR1/2 during apoptosis, we tested its ability to induce
NDR1 activation in a series of kinase assays. MST1, but
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Figure 1. Death Receptor-Induced NDR Activation Is Mediated by RASSF1A and MST1
(A) Top: HeLa cells were treated with cycloheximide (CHX) alone or in combination with Fas antibody or TNF-a for the indicated time periods. Cell lysates
were analyzed for the phosphorylation of NDR1/2 (Thr444/442) and MST1/2 (Thr183/Thr180) and PARP cleavage by western blotting. Bottom: Immunopre-
cipitated NDR1/2 from HeLa cells treated with CHX, Fas antibody, or TNF-a for 6 hr was assayed for kinase activity. The results are from duplicate assays
from two independent experiments; data show mean 6 standard deviation.
(B) GFP-RASSF1A was overexpressed in H1299 cells with subsequent analysis of NDR Thr444/Thr442 phosphorylation either by western blotting with
Odyssey quantification (top) or by confocal microscopy (bottom). Note that cells expressing GFP-RASSF1A stained more intensely for Thr444/442 phos-
phorylated NDR1/2 than did untransfected cells (arrows).
(C) HeLa cells expressing shRNA against RASSF1A and treated with a combination of CHX and Fas antibody for 6 hr were lysed and processed for west-
ern blotting. The results are from three independently quantified experiments; data show mean 6 standard deviation.
(D) HeLa cells expressing shRNA against MST1 and treated with a combination of CHX and Fas antibody for 6 hr were lysed and assessed by western
blotting for the occurrence of the indicated proteins.
(E) GFP-RASSF1A was overexpressed in H1299 cells along with the shRNA against MST1, NDR Thr444/Thr442 phosphorylation was analyzed by western
blotting.not its kinase dead variant, phosphorylated MBP-NDR1 pro-
tein in vitro (Figure 2A, left). Next, we confirmed that MST1
was able to directly phosphorylate MBP-NDR1 at the hydro-
phobic motif (Thr444) (Figure 2A, top right), raising the ques-
tion of whether this phosphorylation also induced NDR1/2
activation. Indeed, NDR1 phosphorylated at Thr444 by
MST1 displayed greatly (7-fold) enhanced protein kinaseactivity (Figure 2A, bottom right). In order to verify the spec-
ificity of the kinase reaction, we performed experiments with
recombinant MST1 (Figures S2A and S2B). Finally, we deter-
mined whether MST2 and MST4 are also potential upstream
kinases for NDR. Although MST1, MST2, and MST3 potently
activated NDR1 in vitro, MST4 had only a minor effect
(Figure S2C).
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Figure 2. MST1 Phosphorylates and Activates NDR In Vitro and In Vivo
(A) MBP-NDR1 was in vitro phosphorylated in the presence of [g-32P]ATP by Flag-MST1 and its kinase dead variant (MST1KD) immunoprecipitated from
HEK293 lysates. Kinase reactions were resolved on the SDS-PAGE (left). Experiment performed as above but in the absence of radiolabelled ATP and
NDR1 Thr444 phosphorylation was analyzed by western blotting (right). MBP-NDR1 activated by MST1 was used in a subsequent in vitro kinase assay
on the NDR substrate peptide (right). The results are from duplicate assays from two independent experiments: data show mean 6 standard deviation.
(B) HEK293 cells were transfected with Flag-MST1 or Flag-MST1KD, cell lysates were analyzed for phosphorylated active NDR1/2 by western blotting and
quantified.
(C) HA-RASSF1A and Flag-MST1 as well as their SARAH domain deletion mutants were expressed in H1299 cells; western blotting of the indicated proteins
is shown.
(D) Putative phosphorylation sites (Thr202Ser203) in the sequence of RASSF1A are displayed (top). HA-MST1, immunoprecipitated from the HEK293 cells,
was used in an in vitro radioactive kinase assay with MBP-RASSF1A or its phospho-deficient mutant Thr/Ala202Ser/Ala203.
(E) HeLa cells were transfected with wild-type HA-RASSF1A or phosphorylation-deficient mutant, and activation of NDR1/2 by Thr444/Thr442 phosphory-
lation was assessed by western blotting.
(F) Apoptosis of HeLa cells expressing wild-type RASSF1A versus a RASSF1A-Thr/Ala202Ser/Ala203 mutant upon Fas antibody treatment. Data including
standard deviations from three independent experiments are displayed.The contribution of MST1 to in vivo phosphorylation and ac-
tivation of NDR was studied by expressing the kinase in
HEK293 cells. MST1 induced significant phosphorylation of
NDR1/2 on Thr444/442 (Figure 2B), comparable with that in-
duced by RASSF1A expression (Figure 1B), Fas antibody, or
TNF-a treatment (Figure 1A). Next, we examined whether theobserved increase in NDR Thr444/442 phosphorylation was
mediated by RASSF1A-MST1 binding via their SARAH do-
mains [7, 22]. As expected, wild-type MST1 coimmunoprecipi-
tated with RASSF1A, whereas the MST1 mutant lacking the
SARAH domain (DSAR) as well as MST3 (naturally lacking
a SARAH domain) failed to bind RASSF1A (Figure S2D).
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1892Comparison of NDR1/2 phosphorylation in cells expressing
wild-type or SARAH domain-deletion variants (DSAR) of
RASSF1A, MST1, or their combination showed that interaction
of RASSF1A and MST1 is required for a positive effect on NDR
Thr444/442 phosphorylation (Figure 2C).
Our data place mammalian NDR1/2 directly downstream of
the MST1 kinase. In Drosophila, the ortholog of NDR (Trc), as
well as of LATS (Warts/Lats), are also regulated by MST
(Hpo), a core member of Hippo tumor suppressor pathway [23].
We examined whether RASSF1A may be a substrate of NDR
or MST1. The direct phosphorylation of MBP-RASSF1A fusion
protein in in vitro kinase assays with the wild-type or kinase
dead variants revealed a marked effect of MST1 but not of
NDR1 (Figure S2E). We then mutated two putative phosphory-
lation sites in the MBP-RASSF1A construct (Figure 2D, top).
MST1 efficiently phosphorylated MBP-RASSF1A, whereas
MBP-RASSF1A Thr/Ala202Ser/Ala203 displayed only a residual
signal (Figure 2D, bottom). To investigate the effects of puta-
tive RASSF1A phosphorylation in vivo, mutant RASSF1A was
expressed along with the wild-type species. Interestingly,
analysis of NDR Thr444/442 phosphorylation demonstrated
a reduced capacity of the RASSF1A mutant to activate
NDR1/2 (Figure 2E). It has been reported previously that over-
expression of RASSF1A is sufficient to induce apoptosis [4, 7,
8]. We found that the mutant RASSF1A was less potent in trig-
gering apoptosis than the wild-type protein (Figure 2F). MST1
and RASSF1A form a complex via association of their SARAH
domains [24]. This interaction could facilitate MST1-mediated
RASSF1A phosphorylation upon induction of apoptosis [25].
The same motif (Thr202Ser203) was previously shown to be tar-
geted by Aurora-A [26] and CDK4 [27]. However, phosphoryla-
tion of RASSF1A by these kinases results mostly in effects on
the cell cycle and no apoptotic function has been proposed.
Previously, we established that full activation of NDR1/2 de-
pends on the MOB1 coactivator, which elicits its effect through
direct binding to the N termini of NDR1 and NDR2 [14, 28]. Hu-
man MOB1 protein exists in two isoforms that share more than
95% sequence similarity: MOB1A and B (collectively termed as
MOB1 hereafter). In order to study the role of MOB1 in NDR ac-
tivation during apoptosis, we knocked down both MOB1 iso-
forms in HeLa cells and treated with the Fas antibody. In these
experimental settings, a decrease in MOB1 protein level corre-
lated with reduced Thr444/442 phosphorylation of NDR1/2
(Figure 3A). Further, coexpression of MOB1A and MST1 re-
sulted in enhanced NDR1 activity (Figure 3B). In vitro kinase
assays with MBP-NDR1 as a substrate revealed a stimulatory
effect of MOB1A on MST1-induced NDR phosphorylation
(Figure S3A).
We showed earlier that MOB1A binds to NDR1 kinase and
that this association is increased upon okadaic acid (OA) treat-
ment, which preferentially inhibits protein phosphatase 2A
[14]. Recent studies also demonstrated association of Dro-
sophilaMats (MOB) and Warts/Lats (LATS) when Mats is phos-
phorylated by Hpo (MST) [29]. Based on these results, we
examined whether human MOB1A and MST1 interact in the
presence of OA. Indeed, MOB1A, MST1, and activated
NDR1/2 were found in a complex upon OA treatment (Figures
S3B and S3C). Moreover, all three proteins displayed cytoplas-
mic colocalization visualized by confocal microscopy
(Figure 3C, top). The inducible knockdown of MOB1 almost
completely abolished binding between endogenous MST1
and HA-NDR1 (Figure 3C, bottom).
Because Fas receptor stimulation activated both MST1 and
NDR1/2, we examined whether this stimulus could serve asa physiological signal for complex formation. Indeed, we ob-
served association of endogenous MOB1-MST1-NDR pro-
teins, triggered by the Fas antibody treatment. In addition,
shRNA against MOB1 was sufficient for disruption of the com-
plex (Figure 3D), implying that MOB1 was its driving force. Our
results support a model in which MOB1 binding not only re-
leases the autoinhibitory conformation of NDR1/2 [14, 30],
but also promotes maximal activation by inducing a triple
complex formation, essential for MST1-mediated phosphory-
lation. During the preparation of this manuscript, a report
was published that describes the association between
MST2, MOB1, and NDR1 [31]. However, it is not known
whether these proteins form an endogenous complex or which
physiological stimulus is required for this association.
Given that activation of NDR1/2 occurred in response to
death receptor stimulation and involved several prominent
proapoptotic molecules, we were prompted to investigate
the functional relevance of NDR1/2 in the apoptotic process.
To address this issue, we made use of HeLa cells expressing in-
ducible shRNA directed against NDR1/2. Cells depleted of
NDR1/2 were more resistant in developing morphological signs
of apoptosis such as membrane blebbing and cellular shrink-
age upon addition of the Fas antibody (Figure 4A, top). In the
same experimental settings, knockdown of NDR1/2 resulted
in a significant reduction of cleaved PARP and cytochrome c
release in cells undergoing apoptosis (Figure 4A, bottom).
The proapoptotic effect of NDR1/2 was further confirmed by
assessing the mitochondrial membrane potential (DJ), which
is a critical factor in the irreversible phase of apoptosis. Loss
of DJ induced by the Fas antibody was significantly lower in
cells depleted of NDR1/2 than in control HeLa cells
(Figure 4B). Transient knockdown of NDR1/2 in HeLa and
MCF7 cells had a similar effect (Figures S4A and S4B). The ex-
pression of siRNA-resistant wild-type NDR1 or NDR2 allowed
Fas-induced apoptosis, whereas reintroduction of siRNA-
resistant kinase dead (or even more so Thr444Ala) mutants
did not restore efficient induction of apoptosis (Figure 4C).
These data confirm that phosphorylation of the hydrophobic
motif as part of NDR activation mechanism is crucial for proa-
poptotic function of NDR kinases. In addition, it shows that
bothNDR1and NDR2 isoformsmediate Fas-induced apoptosis.
We addressed the relevance of NDR1/2 for RASSF1A-medi-
ated apoptosis. Even though both NDR1/2 knockdown and
control cells expressed comparable RASSF1A levels, apopto-
sis was not efficiently induced in the absence of NDR1/2, indi-
cating that these kinases are essential for RASSF1A-mediated
cell death (Figure 4D). Overexpression of NDR1 significantly
enhanced the release of the apoptotic markers, in particular
cytochrome c (Figure S4C, top), and further potentiated apo-
ptosis triggered by the Fas antibody (Figure S4C, bottom). Fur-
thermore, overexpression of NDR1wt but not NDR1Thr444Ala
mutant promoted apoptosis in MCF7 cells (Figure S4D). Signif-
icantly, depletion of endogenous MOB1 resulted in similar re-
duction in apoptotic response as knockdown of NDR (Figures
S4A and S4B). Our data identify NDR1/2 as key apoptotic
players downstream of RASSF1A/MST1/MOB1 and provide
evidence for this novel NDR kinase function, as summarized
schematically in Figure 4F.
Our results, together with the data on MST2-mediated acti-
vation of LATS [8, 10], suggest that the analog of the Hippo
pathway in mammals splits at the level of MST kinases to acti-
vate LATS and NDR.
Whereas MST1 and 2 have been assigned a proapoptotic
function and MOB1 and LATS1/2 are known tumor
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Figure 3. MOB1 Is Required for the Association of NDR and MST1 and for NDR Activation during Fas-Induced Apoptosis
(A) HeLa cells expressing shRNA against MOB1 and treated with a combination of CHX and Fas antibody for 6 hr were lysed and processed for western
blotting with the indicated antibodies. The results are from three independently quantified experiments: data show mean 6 standard deviation.
(B) HA-NDR1 precipitated from HEK293 cells transfected with either MST1 and MOB1A alone or their combination and was assayed for kinase activity on
NDR substrate peptide. The results are from duplicate assays from two independent experiments; data show mean 6 standard deviation.
(C) Indicated proteins were expressed in HeLa cells and their colocalization analyzed by confocal microscopy (top). HA-NDR1 expressed in U2OS with
tetracycline-regulated shRNA against human MOB1 stimulated with okadaic acid (OA) was coimmunoprecipitated with endogenous MST1 in the absence
of inducible MOB1 knockdown (bottom).
(D) Endogenous NDR1/2 were coimmunoprecipitated with endogenous MST1 after stimulation with Fas antibody from U2OS cells expressing inducible
knockdown of MOB1 (compare lines 3 and 6).
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Figure 4. NDR Mediates Fas-Induced Apoptosis
(A) Images of HeLa cells expressing tet-inducible shRNA against NDR1/2 after 6 hr of stimulation with CHX alone or in combination with Fas antibody. Cells
were lysed and analyzed by quantitative western blotting with the antibodies against total and active NDR1/2 (phospho-Thr444/Thr442), cleaved PARP, and
cytochrome c. The results are from three independent experiments; data show mean 6 standard deviation.
(B) Cells treated as in (A) were analyzed for depolarization of mitochondrial membrane potential by flow cytometry. Note that knockdown of NDR1/2 signif-
icantly reduced the number of cells undergoing apoptosis. Data including standard deviations from three independent experiments are displayed;
*p < 0.005.
(C) HeLa cells expressing tet-inducible shRNA against NDR1/2 were transfected with empty vector, HA-NDR1 wild-type, kinase dead, Thr444Ala mutant, or
HA-NDR2 wild-type that is refractory to siRNA [1wt(6N), 1kd(6N), 1T444A(6N), or 2wt(6N)]. Cells were treated as in (A) and analyzed for depolarization of
mitochondrial membrane potential by flow cytometry. Data including standard deviations from three independent experiments are displayed.
(D) Apoptotic response to HA-RASSF1A overexpression was measured by flow cytometry in HeLa cells expressing tet-inducible shRNA against NDR1/2.
Knockdown of NDR1/2 and expression levels of HA-RASSF1A were monitored by western blotting. Data including standard deviations from three indepen-
dent experiments are displayed; *p < 0.005.
(E) Schematic representation of the signaling pathway triggered by Fas receptor stimulation with the subsequent activation of NDR1/2 via the RASSF1A/
MST1.suppressors [32–34], the possible involvement of NDR1/2 in
cell transformation has not yet been addressed. The pathway
we describe highlights the importance of NDR1/2 in theregulation of apoptosis and contributes to the mechanism of
death receptor signaling, which is a part of antitumor defense
and is often compromised in cancer.
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